Zelnorm was marketed in Canada between March, 2002 and March, 2007 for the treatment of IBS symptoms. At the request of the Canadian health department, Novartis pulled the drug from the market. This was based on analysis of clinical data the showed a significant increase in the incidence or cardiovascular events in people taking Zelnorm.

read more from this topic.....